Medication info
Trusita Tablets 100 Milligrams (Sitagliptin Hydrochloride Hydrate)

Trusita Tablets 100 Milligrams (Sitagliptin Hydrochloride Hydrate)

Prescription medicationTablet
Ingredient · strength
Sitagliptin Hydrochloride Hydrate›113.4mg / 1 tablet
Manufacturer / importer
Boryung Co., Ltd.
Appearance
Light brown, round, double-convex film-coated tablets
Packaging
PTP - 28 tablets/box [(14 tablets/PTP×2)]
Approval status
Active

MFDS item code 202101848 · Approved 2021.02.24 · Insurance code 641908140

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who uses it
Adults
Adult dosage
Administer 100 mg once daily as monotherapy or in combination therapy; the maximum daily dose is 100 mg. This medication may be taken with or without food. When administered in combination with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions, 5. General Precautions). Because dosage adjustment is required according to renal function, assessment of renal function is recommended before treatment with this medication and periodically during treatment. No dosage adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). No dosage adjustment is necessary in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). Administer 50 mg once daily to patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). Administer 25 mg once daily to patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medication may be administered without regard to the timing of dialysis.

Ingredients

Manufacturer
Boryung Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Type 2 diabetes
  • difficulty in blood sugar control
View approved original text

This medication is used to help control blood sugar in patients with type 2 diabetes. Initially, it may be administered alone, and if blood sugar control is difficult with monotherapy, it can be taken in combination with metformin. Additionally, it can complement blood sugar control when used together with other diabetes medications such as sulfonylureas, thiazolidinediones, and insulin. When various combination therapies are insufficient for blood sugar control, this medication can be added to enhance treatment efficacy. This medication helps improve blood sugar control in conjunction with diet and exercise therapy.

Dosage and Administration

Adult dosage

Administer 100 mg once daily as monotherapy or in combination therapy; the maximum daily dose is 100 mg. This medication may be taken with or without food. When administered in combination with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions, 5. General Precautions). Because dosage adjustment is required according to renal function, assessment of renal function is recommended before treatment with this medication and periodically during treatment. No dosage adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). No dosage adjustment is necessary in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). Administer 50 mg once daily to patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). Administer 25 mg once daily to patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medication may be administered without regard to the timing of dialysis.

Precautions

This medication may cause severe allergic reactions after use, so if symptoms such as skin rash or difficulty breathing occur, you should stop taking it immediately and consult a doctor. While taking this medication, symptoms of pancreatitis such as severe abdominal pain, vomiting, and fever may appear, so you should inform healthcare professionals immediately if these symptoms occur. Patients with type 1 diabetes or diabetic ketoacidosis should not take this medication. If you have allergies to this medication or its components, you must not take it. Patients with impaired kidney function need to adjust the dosage of this medication, and regular kidney function tests are essential. Hypoglycemia may occur when this medication is used alone or in combination with other diabetes medications, so pay attention to hypoglycemic symptoms and adjust the dosage as needed. Long-term use may lead to side effects such as headache, upper respiratory infection, nasopharyngitis, diarrhea, nausea, abdominal pain, constipation, myalgia, limb pain, back pain, pruritus, thrombocytopenia, indigestion, dizziness, increased blood triglycerides, increased low-density lipoproteins, hyperglycemia, hypernatremia, erectile dysfunction, weight loss, and hypertension. This medication can be used in elderly patients, but care should be taken to determine the dosage considering the possibility of decreased kidney function. Women who are pregnant or breastfeeding should avoid taking this medication, and its safety and efficacy have not been established in children and adolescents, so it is not used in this population. There are few interactions between this medication and certain drugs, but caution is needed when taken with digoxin or cyclosporine, and it should be taken according to the healthcare professional's instructions. In case of overdose, immediately go to the hospital for appropriate treatment, as some may be removed by hemodialysis. If severe joint pain or blisters occur while taking this medication, stop taking it immediately and seek professional medical attention.

Side effects

  • Anaphylaxis
  • angioedema
  • Stevens-Johnson syndrome
  • acute pancreatitis
  • hypoglycemia
  • upper respiratory tract infection
  • nasopharyngitis
  • headache
  • diarrhea
  • abdominal pain
Show 26 more
  • nausea
  • peripheral edema
  • constipation
  • vomiting
  • severe and debilitating arthralgia
  • blistering dermatosis
  • myalgia
  • limb pain
  • back pain
  • interstitial lung disease
  • pruritus
  • thrombocytopenia
  • rhabdomyolysis
  • dyspepsia
  • dizziness
  • elevated liver enzymes
  • acute renal failure
  • rash
  • urticaria
  • cutaneous vasculitis
  • increased serum triglycerides
  • gastritis
  • weight loss
  • hypertension
  • hypernatremia
  • erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent air exposure, and it is best kept at room temperature between 1 to 30 degrees Celsius. By storing it this way, the medication's efficacy can be maintained for a longer period.

Appearance and packaging

Appearance

Light brown, round, double-convex film-coated tablets

Package unit

PTP - 28 tablets/box [(14 tablets/PTP×2)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.